225 related articles for article (PubMed ID: 32339025)
1. Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.
Kirtane AJ; Bangalore S
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006885. PubMed ID: 32339025
[No Abstract] [Full Text] [Related]
2. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.
Bainey KR; Bates ER; Armstrong PW
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006834. PubMed ID: 32339038
[No Abstract] [Full Text] [Related]
3. No Reduction of ST-segment Elevation Myocardial Infarction Admission in Taiwan During Coronavirus Pandemic.
Li YH; Huang WC; Hwang JJ;
Am J Cardiol; 2020 Sep; 131():133-134. PubMed ID: 32713656
[No Abstract] [Full Text] [Related]
4. Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes.
Wilson SJ; Connolly MJ; Elghamry Z; Cosgrove C; Firoozi S; Lim P; Sharma R; Spratt JC
Circ Cardiovasc Interv; 2020 Jul; 13(7):e009438. PubMed ID: 32600109
[No Abstract] [Full Text] [Related]
5. Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?
Daniels MJ; Cohen MG; Bavry AA; Kumbhani DJ
Circulation; 2020 Jun; 141(24):1948-1950. PubMed ID: 32282225
[No Abstract] [Full Text] [Related]
6. The Obstacle Course of Reperfusion for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic.
Roffi M; Guagliumi G; Ibanez B
Circulation; 2020 Jun; 141(24):1951-1953. PubMed ID: 32315205
[No Abstract] [Full Text] [Related]
7. Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era.
Elbadawi A; Mahtta D; Elgendy IY; Saad M; Krittanawong C; Hira RS; Omer M; Ogunbayo GO; Garratt K; Rao SV; Jneid H
JACC Cardiovasc Interv; 2020 Oct; 13(19):2312-2314. PubMed ID: 33032721
[No Abstract] [Full Text] [Related]
8. Assessment of ST-Segment Elevation Myocardial Infarction Volume Trends During The COVID-19 Pandemic.
Lotfi AS; Capatina A; Kugelmass AD
Am J Cardiol; 2020 Sep; 131():132-133. PubMed ID: 32732009
[No Abstract] [Full Text] [Related]
9. Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic.
Yerasi C; Case BC; Forrestal BJ; Chezar-Azerrad C; Hashim H; Ben-Dor I; Satler LF; Mintz GS; Waksman R
Cardiovasc Revasc Med; 2020 Aug; 21(8):1024-1029. PubMed ID: 32471712
[TBL] [Abstract][Full Text] [Related]
10. Primary Percutaneous Coronary Intervention or Fibrinolytic Therapy in COVID 19 Patients Presenting With ST-Segment Elevation Myocardial Infarction.
Sudhakar D; Jneid H; Lakkis N; Kayani WT
Am J Cardiol; 2020 Nov; 134():158. PubMed ID: 32841613
[No Abstract] [Full Text] [Related]
11. Comparison of Clinical Outcomes in Patients with ST Elevation Myocardial Infarction with Percutaneous Coronary Intervention and the Use of a Telemedicine App Before and After the COVID-19 Pandemic at a Center in Beijing, China, from August 2019 to March 2020.
Nan J; Meng S; Hu H; Jia R; Chen W; Li Q; Zhang T; Song K; Wang Y; Jin Z
Med Sci Monit; 2020 Sep; 26():e927061. PubMed ID: 32938901
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 (SARS-CoV-2) and the Heart - An Ominous Association.
Khalid N; Chen Y; Case BC; Shlofmitz E; Wermers JP; Rogers T; Ben-Dor I; Waksman R
Cardiovasc Revasc Med; 2020 Aug; 21(8):946-949. PubMed ID: 32423791
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-Specific Strategies for the Treatment of ST-Segment Elevation Myocardial Infarction in China.
Ranard LS; Parikh SA; Kirtane AJ
J Am Coll Cardiol; 2020 Sep; 76(11):1325-1327. PubMed ID: 32807587
[TBL] [Abstract][Full Text] [Related]
14. [Analysis on the efficacy and safety of fibrinolytic therapy in patients with acute ST-segment elevation myocardial infarction during the COVID-19 epidemic].
Wei F; Shuai XX; Chen ZJ; Cao GL; Wang L; Qiu T; Hu T; Wu L; Zhang Q; Huang HX; Zhang YW; Zhu L; Cheng X
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jun; 48(6):472-476. PubMed ID: 32842256
[No Abstract] [Full Text] [Related]
15. Delay, Death, and Heterogeneity of Primary PCI During the COVID-19 Pandemic: An International Perspective.
Park DW; Yang Y
J Am Coll Cardiol; 2020 Nov; 76(20):2331-2333. PubMed ID: 33183507
[TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 Pandemic on Critical Care Transfers for ST-Segment-Elevation Myocardial Infarction, Stroke, and Aortic Emergencies.
Khot UN; Reimer AP; Brown A; Hustey FM; Hussain MS; Kapadia SR; Svensson LG
Circ Cardiovasc Qual Outcomes; 2020 Aug; 13(8):e006938. PubMed ID: 32524835
[No Abstract] [Full Text] [Related]
17. Declines in Acute Cardiovascular Emergencies During the COVID-19 Pandemic.
Zaleski AL; Taylor BA; McKay RG; Thompson PD
Am J Cardiol; 2020 Aug; 129():124-125. PubMed ID: 32593434
[No Abstract] [Full Text] [Related]
18. COVID-19 pandemic and infarctions: another call to reorganise our healthcare systems.
De Filippo O; D'Ascenzo F; Deferrari GM
Heart; 2020 Dec; 106(23):1786-1787. PubMed ID: 33087411
[No Abstract] [Full Text] [Related]
19. Decrease in ST-segment elevation myocardial infarction admissions in Catalonia during the COVID-19 pandemic.
Romaguera R; Ribera A; Güell-Viaplana F; Tomás-Querol C; Muñoz-Camacho JF; Agudelo V;
Rev Esp Cardiol (Engl Ed); 2020 Sep; 73(9):778-780. PubMed ID: 32565077
[No Abstract] [Full Text] [Related]
20. Standards of Care in Crisis: ST-Segment-Elevation Myocardial Infarction Management in COVID-19.
Mihatov N; Kirtane AJ
Circ Cardiovasc Interv; 2020 Nov; 13(11):e010143. PubMed ID: 33167704
[No Abstract] [Full Text] [Related]
[Next] [New Search]
